@article{article, title  = {{Navelbine® (NVB) alternating oral and i.v. plus epirubicin (EPI) as first line chemotherapy of metastatic breast cancer (MBC): phase II study — final results}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2004}},

 month = {{3}},

 author = {{Serin D and Verrill M and Jones A and Delozier T and Coleman R and Longerey B and Lafaye de Micheaux S}},

 doi = {{10.1016/s1359-6349(04)90860-9}},

 volume = {{2}},

 journal = {{European Journal of Cancer Supplements}},

 issue = {{3}},

 pages = {{130-131}},

 note = {{Accessed on 2025/10/10}}}